Isaac is a Staff Scientist in the Synthetic Biology Platform who first joined the Wyss in 2017 as part of an effort to commercialize gene therapy technologies coming out of the Church lab. He has a diverse scientific background with a focus on molecular biology, assay development, and viral vector engineering. He is currently leading a Wyss Validation Project for development and commercialization of a novel biosensor technology, and also supports multiple synthetic biology and gene delivery efforts across the Institute.